Diamyd Medical AB intends to carry out a directed share issue of B-shares
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL. Diamyd Medical AB (publ) (“Diamyd Medical” or “the Company”) today announces its intention to carry out a directed share issue corresponding to approximately SEK 60 million through a so-called accelerated bookbuilding process. The objective of the directed share issue is to support the Company regarding the pivotal Phase 3